Apollo Endosurgery, Inc.
NASDAQ: APEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Charles S. McKhann
- Employees
- 202
- Headquarters
- Austin, United States
- IPO year
- 2005
- Market cap
- $579.7M
- Website
- https://www.apolloendo.com
Loading APEN…
Loading profile data…Frequently asked questions about APEN
What does Apollo Endosurgery, Inc. (APEN) do?
Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximati...
Where does APEN trade?
Apollo Endosurgery, Inc. (APEN) trades on the NASDAQ Global Market.
What sector is APEN in?
Apollo Endosurgery, Inc. (APEN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Apollo Endosurgery, Inc.?
Charles S. McKhann is the chief executive officer of Apollo Endosurgery, Inc. (APEN).
Where is Apollo Endosurgery, Inc. headquartered?
Apollo Endosurgery, Inc. is headquartered in United States.
Does APEN pay a dividend?
Apollo Endosurgery, Inc. (APEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APEN go public?
Apollo Endosurgery, Inc. (APEN) completed its initial public offering in 2005.